1094P - Clinical prognostic factors in patients (pts) with recurrent and/or metastatic (RM) head and neck carcinoma (HNC) treated with cetuximab plus chemotherapy

Autor: Bossi, P., Depenni, R., cossu rocca, M., Ferrari, D., Azzarello, G., Alù, M., Nolè, F., Codecà, C., Boscolo, G., Piccininni, M., Cavalieri, S., Pugliese, G., Licitra, L.F.
Zdroj: In Annals of Oncology October 2018 29 Supplement 8
Databáze: ScienceDirect